GlassScriptPhysician profile
Mark Alan Colquitt
NPI 1841307295
$6,231.19
in general payments reported to CMS, 2019-2025
22 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $272 · 2021: $402 · 2022: $4,667 · 2023: $251 · 2024: $103 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,230.56 | 2019-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $395.46 | 2019-2022 | |
| Conmed Corporation | $96.35 | 2023 | Airseal |
| W. L. Gore & Associates, INC. | $49.11 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Merck Sharp & Dohme LLC | $45.24 | 2022 | |
| Davol INC. | $43.88 | 2025 | Phasix Mesh |
| Medtronic, INC. | $43.19 | 2024 | Venaseal |
| Daiichi Sankyo INC. | $40.33 | 2022 | |
| Mesh Suture INC | $30.15 | 2025 | |
| Endo Pharmaceuticals INC. | $30.07 | 2020 | |
| Innocoll Pharmaceuticals Limited | $25.12 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $24.06 | 2022 | |
| Ambu INC. | $22.68 | 2022 | |
| Microline Surgical INC | $22.11 | 2024 | |
| Solventum Corporation | $22.05 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Prevena |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $19.44 | 2024 | Talicia |
| Novo Nordisk INC | $18.87 | 2020 | |
| Teleflex LLC | $17.00 | 2022 | |
| Integra Lifesciences Corporation | $15.84 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Lilly USA, LLC | $15.15 | 2025 | Zepbound |
| Currax Pharmaceuticals LLC | $13.88 | 2023 | Contrave |
| Merit Medical Systems INC | $10.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Colquitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.